The World Health Organization (WHO) is launching an international clinical trial to study the use of lupus treatments…
Articles by Catarina Silva, MSc
Adding Benlysta (belimumab) to standard therapy increased the percentage of people with active lupus nephritis who experienced…
Treatment with an investigational antibody therapy known as BIIB059 was well-tolerated and decreased disease activity in people with cutaneous…
High blood pressure and a skin condition characterized by a netlike pattern of reddish-blue skin discoloration — livedo reticularis —…
Systemic lupus erythematosus (SLE) patients treated Benlysta (belimumab) together with standard of care showed significantly lesser evidence of long-term…
Lupus nephritis patients with reduced kidney function and high levels of “good” cholesterol are at a greater risk…